{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:11:07Z","timestamp":1778490667146,"version":"3.51.4"},"reference-count":35,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Madin-Darby canine kidney (MDCK) cell line is frequently used for permeability screening in drug discovery. It contains endogenous transporters, most prominently canine multidrug resistance P-glycoprotein (Mdr1), which can interfere with studies of P-glycoprotein substrate assessment and permeability measurements. Because MDCK wild type (WT) is genetically heterogeneous, an isolation procedure was investigated in this study to obtain the subclonal line with low P-glycoprotein expression. The best clone obtained had up to 3-fold lower amprenavir efflux and P-glycoprotein expression in comparison to WT. Of 12 standard compounds tested that exhibited active efflux in WT cells, 11 showed a decrease in efflux in the isolated clone. However, the decrease was not below the cut-off value of 2, indicating residual P--glycoprotein activity. Clone isolation\n                    <jats:italic>via<\/jats:italic>\n                    the limiting dilution method, combined with bidirectional amprenavir permeability for clone selection, successfully identified MDCK clones with substantially lower P-glycoprotein efflux and has been demonstrated as a useful tool for assessing passive permeability in early drug discovery.\n                  <\/jats:p>","DOI":"10.2478\/acph-2022-0003","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T09:56:57Z","timestamp":1642240617000},"page":"275-288","source":"Crossref","is-referenced-by-count":14,"title":["Isolation of MDCK cells with low expression of\n                    <i>mdr1<\/i>\n                    gene and their use in membrane permeability screening"],"prefix":"10.2478","volume":"72","author":[{"given":"ANA","family":"BOKULI\u0106","sequence":"first","affiliation":[{"name":"Fidelta Ltd. , Zagreb , Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JASNA","family":"PADOVAN","sequence":"additional","affiliation":[{"name":"Fidelta Ltd. , Zagreb , Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DARIJA","family":"STUPIN-POLAN\u010cEC","sequence":"additional","affiliation":[{"name":"Fidelta Ltd. , Zagreb , Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ASTRID","family":"MILI\u0106","sequence":"additional","affiliation":[{"name":"Fidelta Ltd. , Zagreb , Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"2026051108205906455_j_acph-2022-0003_ref_1","doi-asserted-by":"crossref","unstructured":"P. Li, Preclinical in vitro screening assays for drug-like properties, Drug Discov. Today Technol. 2 (2005) 179\u2013185; https:\/\/doi.org\/10.1016\/j.ddtec.2005.05.02410.1016\/j.ddtec.2005.05.024","DOI":"10.1016\/j.ddtec.2005.05.024"},{"key":"2026051108205906455_j_acph-2022-0003_ref_2","doi-asserted-by":"crossref","unstructured":"D. A. Volpe, Drug-permeability and transporter assays in Caco-2 and MDCK cell lines, Future Med. Chem. 3 (2011) 2063\u20132077; https:\/\/doi.org\/10.4155\/fmc.11.14910.4155\/fmc.11.149","DOI":"10.4155\/fmc.11.149"},{"key":"2026051108205906455_j_acph-2022-0003_ref_3","doi-asserted-by":"crossref","unstructured":"P. Artursson and J. Karlsson, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem. Biophys. Res. Commun. 175 (1991) 880\u2013885; https:\/\/doi.org\/10.1016\/0006-291X(91)91647-U10.1016\/0006-291X(91)91647-U","DOI":"10.1016\/0006-291X(91)91647-U"},{"key":"2026051108205906455_j_acph-2022-0003_ref_4","doi-asserted-by":"crossref","unstructured":"S. Yee, In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man \u2013 fact or myth, Pharm. Res. 14 (1997) 763\u2013766; https:\/\/doi.org\/10.1023\/a:101210252278710.1023\/A:1012102522787","DOI":"10.1023\/A:1012102522787"},{"key":"2026051108205906455_j_acph-2022-0003_ref_5","doi-asserted-by":"crossref","unstructured":"D. Newby, A. A. Freitas and T. Ghafourian, Decision trees to characterise the roles of permeability and solubility on the prediction of oral absorption, Eur. J. Med. Chem. 90 (2015) 751\u2013765; https:\/\/doi.org\/10.1016\/j.ejmech.2014.12.00610.1016\/j.ejmech.2014.12.00625528330","DOI":"10.1016\/j.ejmech.2014.12.006"},{"key":"2026051108205906455_j_acph-2022-0003_ref_6","doi-asserted-by":"crossref","unstructured":"J. D. Irvine, L. Takahashi, K. Lockhart, J. Cheong, J. W. Tolan, H. E. Selick and J. R. Grove, MDCK (Madin-Darby Canine Kidney) Cells: A tool for membrane permeability screening, J. Pharm. Sci. 88 (1999) 28\u201333; https:\/\/doi.org\/10.1021\/js980320510.1021\/js98032059874698","DOI":"10.1021\/js9803205"},{"key":"2026051108205906455_j_acph-2022-0003_ref_7","doi-asserted-by":"crossref","unstructured":"T. T. Tran, T. Gales, B. Maleeff, T. Aldinger, J. W. Polli, A. Ayrton, H. Ellens, J. Bentz and A. Mittal, Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier, J. Pharm. Sci. 93 (2004) 2108\u20132123; https:\/\/doi.org\/10.1002\/jps.2010510.1002\/jps.2010515236458","DOI":"10.1002\/jps.20105"},{"key":"2026051108205906455_j_acph-2022-0003_ref_8","doi-asserted-by":"crossref","unstructured":"Y. Quan, Y. Jin, T. N. Faria, C. A. Tilford, A. He, D. A. Wall, R. L. Smith and B. S. Vig, Expression profile of drug and nutrient absorption related genes in Madin-Darby Canine Kidney (MDCK) cells grown under differentiation conditions, Pharmaceutics 4 (2012) 314\u2013333; https:\/\/doi.org\/10.3390\/pharmaceutics402031410.3390\/pharmaceutics4020314383491424300234","DOI":"10.3390\/pharmaceutics4020314"},{"key":"2026051108205906455_j_acph-2022-0003_ref_9","doi-asserted-by":"crossref","unstructured":"F. Sharom, The P-glycoprotein multidrug transporter, Essays Biochem. 50 (2011) 161\u2013178; https:\/\/doi.org\/10.1042\/bse050016110.1042\/bse050016121967057","DOI":"10.1042\/bse0500161"},{"key":"2026051108205906455_j_acph-2022-0003_ref_10","doi-asserted-by":"crossref","unstructured":"M. V. S. Varma, K. Sateesh and R. Panchagnula, Functional role of P-glycoprotein in limiting intestinal absorption of drugs: Contribution of passive permeability to P-glycoprotein mediated efflux transport, Mol. Pharmaceutics 2 (2005) 12\u201321, https:\/\/doi.org\/10.1021\/mp049919610.1021\/mp049919615804173","DOI":"10.1021\/mp0499196"},{"key":"2026051108205906455_j_acph-2022-0003_ref_11","doi-asserted-by":"crossref","unstructured":"L.-B. Goh, K. J. Spears, D. Yao, A. Ayrton, P. Morgan, C. R. Wolf and T. Friedberg, Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man, Biochem. Pharmacol. 64 (2002) 1569\u20131578.10.1016\/S0006-2952(02)01355-2","DOI":"10.1016\/S0006-2952(02)01355-2"},{"key":"2026051108205906455_j_acph-2022-0003_ref_12","doi-asserted-by":"crossref","unstructured":"L. Di, C. Whitney-Pickett, J. P. Umland, H. Zhang, X. Zhang, D. F. Gebhard, Y. Lai, J. J. Federico, R. E. Davidson, R. Smith, E. L. Reyner, C. Lee, B. Feng, C. Rotter, M. V. Varma, S. Kempshall, K. Fenner, A. F. El-Kattan, T. E. Liston and M. D. Troutman, Development of a new permeability assay using low-efflux MDCKII cells, J. Pharm. Sci. 100 (2011) 4974\u20134985; https:\/\/doi.org\/10.1002\/jps.2267410.1002\/jps.22674","DOI":"10.1002\/jps.22674"},{"key":"2026051108205906455_j_acph-2022-0003_ref_13","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research (FDA\/CDER), In vitro metabolism- and transporter-mediated drug-drug interaction studies guidance for industry, October, 2017; https:\/\/www.fda.gov\/media\/108130\/download; access date November 10, 2020."},{"key":"2026051108205906455_j_acph-2022-0003_ref_14","doi-asserted-by":"crossref","unstructured":"E. C. Chen, F. Broccatelli, E. Plise, B. Chen, L. Liu, J. Cheong, S. Zhang, J. Jorski, K. Gaffney, K. K. Umemoto and L. Salphati, Evaluating the utility of canine Mdr1 knockout Madin-Darby Canine Kidney I cells in permeability screening and efflux substrate determination, Mol. Pharmaceutics 15 (2018) 5103\u20135113; https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b0068810.1021\/acs.molpharmaceut.8b00688","DOI":"10.1021\/acs.molpharmaceut.8b00688"},{"key":"2026051108205906455_j_acph-2022-0003_ref_15","doi-asserted-by":"crossref","unstructured":"K. Kuteykin-Teplyakov, C. Luna-Tortos, K. Ambroziak and W. Loscher, Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport, Br. J. Pharmacol. 160 (2010) 1453\u20131463.10.1111\/j.1476-5381.2010.00801.x","DOI":"10.1111\/j.1476-5381.2010.00801.x"},{"key":"2026051108205906455_j_acph-2022-0003_ref_16","doi-asserted-by":"crossref","unstructured":"J. M. Arthur, The MDCK cell line is made up of populations of cells with diverse resistive and transport properties, Tissue Cell 32 (2000) 446\u2013450.10.1054\/tice.2000.0135","DOI":"10.1054\/tice.2000.0135"},{"key":"2026051108205906455_j_acph-2022-0003_ref_17","doi-asserted-by":"crossref","unstructured":"I. Simoff, M. Karlgren, M. Backlund, A.-C. Lindstr\u00f6m, F. Z. Gaugaz, P. Matsson and P. Artursson, Complete knockout of endogenous Mdr1 (Abcb1) in MDCK cells by CRISPR-Cas9, J. Pharm. Sci. 105 (2016) 1017\u20131021; https:\/\/doi.org\/10.1016\/S0022-3549(15)00171-910.1016\/S0022-3549(15)00171-9","DOI":"10.1016\/S0022-3549(15)00171-9"},{"key":"2026051108205906455_j_acph-2022-0003_ref_18","doi-asserted-by":"crossref","unstructured":"J. R. Yaron, C. P. Ziegler, T. H. Tran, H. L. Glenn and D. R. A. Meldrum, Convenient, optimized pipeline for isolation, fluorescence microscopy and molecular analysis of live single cells, Biol. Proced. Online 16 (2014) 9; https:\/\/doi.org\/10.1186\/1480-9222-16-910.1186\/1480-9222-16-9402254324834016","DOI":"10.1186\/1480-9222-16-9"},{"key":"2026051108205906455_j_acph-2022-0003_ref_19","doi-asserted-by":"crossref","unstructured":"R. I. Freshney, Cloning and Selection, in Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications, John Wiley & Sons, Ltd., New York 2010, pp. 207\u2013225.10.1002\/9780470649367.ch13","DOI":"10.1002\/9780470649367.ch13"},{"key":"2026051108205906455_j_acph-2022-0003_ref_20","doi-asserted-by":"crossref","unstructured":"K. J. Livak, S. J. Flood, J. Marmaro, W. Giusti, and K. Deetz, Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization, Genome Res. 4 (1995) 357\u2013362; https:\/\/doi.org\/10.1101\/gr.4.6.35710.1101\/gr.4.6.3577580930","DOI":"10.1101\/gr.4.6.357"},{"key":"2026051108205906455_j_acph-2022-0003_ref_21","doi-asserted-by":"crossref","unstructured":"I. Hubatsch, E. G. E. Ragnarsson, and P. Artursson, Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers, Nat. Protoc. 2 (2007) 2111\u20132119; https:\/\/doi.org\/10.1038\/nprot.2007.30310.1038\/nprot.2007.30317853866","DOI":"10.1038\/nprot.2007.303"},{"key":"2026051108205906455_j_acph-2022-0003_ref_22","doi-asserted-by":"crossref","unstructured":"R. Mukkavilli, G. Jadhav and S. Vangala, Evaluation of drug transport in MDCKII-wild type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 cell lines, CPB 18 (2018) 1151\u20131158; https:\/\/doi.org\/10.2174\/138920101966618030809185510.2174\/138920101966618030809185529521222","DOI":"10.2174\/1389201019666180308091855"},{"key":"2026051108205906455_j_acph-2022-0003_ref_23","unstructured":"Sigma-Aldrich, Technical bulletin, CompoZr ADMET\/Tox Cell Lines C2BBe1 BCRP Knockout and Wild Type Cell Lines 24 Well Assay Ready Plates, 2013; https:\/\/www.sigmaaldrich.com\/content\/dam\/sigma-aldrich\/docs\/Sigma\/Bulletin\/1\/mtox1002pc24bul.pdf; access date November 10, 2020."},{"key":"2026051108205906455_j_acph-2022-0003_ref_24","doi-asserted-by":"crossref","unstructured":"P. Acharya, M. P. O\u2019Connor, J. W. Polli, A. Ayrton, H. Ellens and J. Bentz, Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-HMDR1 cells, Drug Metab. Dispos. 36 (2008) 452\u2013460; https:\/\/doi.org\/10.1124\/dmd.107.01730110.1124\/dmd.107.01730117967933","DOI":"10.1124\/dmd.107.017301"},{"key":"2026051108205906455_j_acph-2022-0003_ref_25","unstructured":"The international transporter consortium, membrane transporters in drug development, Nat. Rev. Drug Discov. 9 (2010) 215\u2013236; https:\/\/doi.org\/10.1038\/nrd302810.1038\/nrd3028332607620190787"},{"key":"2026051108205906455_j_acph-2022-0003_ref_26","doi-asserted-by":"crossref","unstructured":"J. Rautio, J. E. Humphreys, L. O. Webster, A. Balakrishnan, J. P. Keogh, J. R. Kunta, C. J. Serabjit-Singh and J. W. Polli, In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: A recommendation for probe substrates, Drug Metab. Dispos. 34 (2006) 786\u2013792; https:\/\/doi.org\/10.1124\/dmd.105.00861510.1124\/dmd.105.00861516455806","DOI":"10.1124\/dmd.105.008615"},{"key":"2026051108205906455_j_acph-2022-0003_ref_27","unstructured":"M. Hacker, W. S. Messer and K. A. Bachmann, Pharmacology: Principles and Practice; Academic Press, San Diego 2009, pp. 176\u2013177."},{"key":"2026051108205906455_j_acph-2022-0003_ref_28","doi-asserted-by":"crossref","unstructured":"M. Karlgren, I. Simoff, M. Backlund, C. Wegler, M. Keiser, N. Handin, J. M\u00fcller, P. Lundquist, A.-C. Jareborg, S. Oswald and P. Artursson, A CRISPR-Cas9 generated MDCK cell line expressing human MDR1 without endogenous canine MDR1 (cABCB1): An improved tool for drug efflux studies, J. Pharm. Sci. 106 (2017) 2909\u20132913; https:\/\/doi.org\/10.1016\/j.xphs.2017.04.01810.1016\/j.xphs.2017.04.01828450237","DOI":"10.1016\/j.xphs.2017.04.018"},{"key":"2026051108205906455_j_acph-2022-0003_ref_29","doi-asserted-by":"crossref","unstructured":"K. A. Lentz, J. W. Polli, S. A. Wring, J. E. Humphreys and J. A. Polli, Influence of passive permeability on apparent P-glycoprotein kinetics, Pharm. Res. 17 (2000) 1456\u20131460; https:\/\/doi.org\/10.1023\/A:100769262221610.1023\/A:1007692622216","DOI":"10.1023\/A:1007692622216"},{"key":"2026051108205906455_j_acph-2022-0003_ref_30","doi-asserted-by":"crossref","unstructured":"E. Gundogdu, E. Karasulu, I. Gonzalez Alvarez and M. Bermejo Sanz, Assessment of fexofenadine hydrochloride permeability and dissolution with an anionic surfactant using Caco-2 cells, Pharmazie 66 (2011) 747\u2013753; https:\/\/doi.org\/10.1691\/ph.2011.1054","DOI":"10.31083\/ph.2011.1054"},{"key":"2026051108205906455_j_acph-2022-0003_ref_31","doi-asserted-by":"crossref","unstructured":"M. Cvetkovic, B. Leake, M. F. Fromm, G. R. Wilkinson and R. B. Kim, OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine, Drug Metab. Dispos. 27 (1999) 866\u2013871.","DOI":"10.1016\/S0090-9556(24)15235-X"},{"key":"2026051108205906455_j_acph-2022-0003_ref_32","doi-asserted-by":"crossref","unstructured":"A. Mili\u0107, V. B. Mihaljevi\u0107, J. Rali\u0107, A. Bokuli\u0107, D. No\u017eini\u0107, B. Tav\u010dar, B. Mildner, V. Muni\u0107, I. Malnar and J. Padovan, A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents, Eur. J. Drug. Metab. Pharmacokinet. 39 (2014) 263\u2013276; https:\/\/doi.org\/10.1007\/s13318-013-0155-810.1007\/s13318-013-0155-824114177","DOI":"10.1007\/s13318-013-0155-8"},{"key":"2026051108205906455_j_acph-2022-0003_ref_33","doi-asserted-by":"crossref","unstructured":"J. Padovan, J. Rali\u0107, V. Letfus, A. Mili\u0107 and V. Benceti\u0107 Mihaljevi\u0107, Investigating the barriers to bioavailability of macrolide antibiotics in the rat, Eur. J. Drug. Metab. Pharmacokinet. 37 (2012) 163\u2013171; https:\/\/doi.org\/10.1007\/s13318-011-0074-510.1007\/s13318-011-0074-522113743","DOI":"10.1007\/s13318-011-0074-5"},{"key":"2026051108205906455_j_acph-2022-0003_ref_34","doi-asserted-by":"crossref","unstructured":"D. Gartzke and G. Fricker, Establishment of optimized MDCK cell lines for reliable efflux transport studies, J. Pharm. Sci. 103 (2014) 1298\u20131304; https:\/\/doi.org\/10.1002\/jps.2390110.1002\/jps.2390124532159","DOI":"10.1002\/jps.23901"},{"key":"2026051108205906455_j_acph-2022-0003_ref_35","doi-asserted-by":"crossref","unstructured":"J. A. Ruell and A. Avdeef, Absorption Screening Using the PAMPA Approach, in Optimization in Drug Discovery (Ed. Z. Yan and G. W. Caldwell), Humana Press, Totowa 2004, pp. 37\u201364.10.1385\/1-59259-800-5:037","DOI":"10.1385\/1-59259-800-5:037"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/acph-2022-0003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:45:06Z","timestamp":1778489106000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/acph-2022-0003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,30]]},"published-print":{"date-parts":[[2022,6,1]]}},"alternative-id":["10.2478\/acph-2022-0003"],"URL":"https:\/\/doi.org\/10.2478\/acph-2022-0003","relation":{},"ISSN":["1846-9558"],"issn-type":[{"value":"1846-9558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,30]]}}}